Zepp Health Corporation Sponsored ADR

ZEPP Technology Consumer Electronics

Zepp Health Corporation Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $258.9 million, up 41.8% from fiscal 2024. In the quarter to June 2026, revenue grew 6.93%, EPS fell 46.9%, free cash flow fell 103.7% and total debt rose 26.4%, each against the same quarter a year earlier.

3.04 0.16 −5.00%
Market cap
$27.1M
P/E
0.0×
Fwd P/E
619×
Dividend yield
—
F-score
5/9
Altman Z
1.01
Beneish M
−2.49
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Piotroski F-Score

+8 more TTM periods

— 5 — —
ROE
(24.35%) (17.15%) (18.76%) (21.23%)
ROA
(11.23%) (7.33%) (7.60%) (7.86%)
ROIC
(9.25%) (8.43%) (8.18%) (10.25%)
Return on Tangible Assets
(208.31%) (324.62%) 135.69% 164.91%
Average Days of Receivables
136.43 103.73 83.77 109.21
Free Cash Flow per Share
0.00 (0.74) 0.00 0.00
Free Cash Flow
— (11.76) — —
Other line items

Show all line items

Columns are period end dates